Preveta
PrivateLast Round
Series A
Extension
Nov 14, 2025
Total Funding Raised
$10.72M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Preveta is a healthtech company that provides an AI-powered care navigation platform designed to ensure cancer patients receive appropriate and timely care.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Healthcare Analytics, Medical AI, EHR & EMR, Patient Engagement
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Preveta Comparables
Compare Preveta with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ONCO, Inc. | 78% | |
| Cencora | 76% | |
| Roche Holding | 73% |
Preveta Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Nov 14, 2025 | ||||
| Series A | Dec 16, 2022 | ||||
| Seed | Mar 26, 2021 | ||||
| Accelerator | Jul 13, 2020 |
Key People
Founding team and executive leadership
Preveta Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Techstars | Accelerator |
| Bullpen Capital | Series A Extension, Series A |
| TSV Capital | Seed |
| MaC Venture Capital | Seed |
| Sovereign's Capital | Series A, Series A Extension |
| TMV | Series A Extension, Series A |
| Navigate Ventures | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 210% MoM, reaching 7.6K.
- May 17, 2026
Monthly visitors grew 168% MoM, reaching 1.3K.
Preveta Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Preveta's valuation, stock price, and market status.
Is Preveta a public or private company?
Preveta is a private company.
What is the current stock price of Preveta?
Preveta is a private company with no public stock price. No recent secondary market data is available.
How much is Preveta worth (valuation)?
Valuation information for Preveta is not publicly available.
Can I buy Preveta stock?
Preveta shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Preveta's last funding round?
Preveta's most recent funding round was Series A Extension on November 14, 2025.
Who are the main investors in Preveta?
Key investors in Preveta include Techstars, TSV Capital, MaC Venture Capital, Sovereign's Capital, Navigate Ventures.
Will Preveta IPO soon?
No public IPO plans have been announced for Preveta.
How can I track Preveta secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Preveta's secondary market activity and sign up for updates.